Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype.

Brazilian Guidelines to HCV treatment (2007) recommended that the irst choice treatment for patients with chronic hepatitis C (CHC) and genotype 2 or 3 is interferon alpha (IFN)

This study aimed to evaluate the association between vitamin D serum levels and inlammatory activity and degree of liver ibrosis in patients with chronic hepatitis C virus

Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature. Chung YH,

The aim of this study was to determine risk factors for adverse events (AE)-related treatment discontinuation and severe anemia among patients with chronic hepatitis C virus

Para responder à questão colocada, este estudo tem o objetivo de identificar na literatura nacional e internacional estudos que tenham como foco a saúde do catador de

The needle is passed through the uterine cavity until its posterior side, where the thread is passed over the fundus until the anterior wall; there, the needle is inserted below the

Accordingly, the purpose of this study was to compare the outcome of patients with chronic systolic heart failure secondary to Chagas cardiomyopathy with that observed in

In this study, the genotype frequency of two IL28B SNPs (rs129679860 and rs8099917) in a cohort of chronic HCV-monoinfected patients in Brazil was evaluated and the SNP sufficient